Abstract:The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a pandemic has been validated as an extreme clinical calamity and has affected several socio-economic activities globally. Proven transmission of this virus occurs through airborne droplets from an infected person. The recent upsurge in the number of infected individuals has already exceeded the number of intensive care beds available to patients. These extraordinary circumstances have elicited the need for the development of diagnostic tools for the detection of the virus and, hence, prevent the spread of the disease. Early diagnosis and effective immediate treatment can reduce and prevent an increase in the number of cases. Conventional methods of detection such as quantitative real-time polymerase chain reaction and chest computed tomography scans have been used extensively for diagnostic purposes. However, these present several challenges, including prolonged assay requirements, labor-intensive testing, low sensitivity, and unavailability of these resources in remote locations. Such challenges urgently require fast, sensitive, and accurate diagnostic techniques for the timely detection and treatment of coronavirus disease 2019 (COVID-19) infections. Point-of-care biosensors that include paper- and chip-based diagnostic systems are rapid, cost-effective, and user friendly. In this article nanotechnology-based potential biosensors for SARS-CoV-2 diagnosis are discussed with particular emphasis on a lateral flow assay, a surface-enhanced Raman scattering-based biosensor, a localized surface plasmon resonance-based biosensor, Förster resonance energy transfer, an electrochemical biosensor, and artificial intelligence-based biosensors. Several biomolecules, such as nucleic acids, antibodies/enzymes, or aptamers, can serve as potential detection molecules on an appropriate platform, such as graphene oxide, nanoparticles, or quantum dots. An effective biosensor can be developed by using appropriate combinations of nanomaterials and technologies.

Magnetic-Nanosensor-Based Virus and Pathogen Detection Strategies before and during COVID-19

Magnetic Immunoassays: A Review of Virus and Pathogen Detection Before and Amidst the Coronavirus Disease-19 (COVID-19)

Detection, Prevention and Treatment of COVID-19 and Opportunities for Nanobiotechnology.

Magnetic biosensors for identification of SARS-CoV-2, Influenza, HIV, and Ebola viruses: a review

Rapid and sensitive detection of SARS-CoV-2 with functionalized magnetic nanoparticles

Nanomaterials and Biosensing Technology for the SARS-CoV-2 Detection

Recent Developments in Nanotechnology-Based Biosensors for the Diagnosis of Coronavirus

Nanomaterials-based electrochemical biosensors for diagnosis of COVID-19

Facile biosensors for rapid detection of COVID-19

A Review of Piezoelectric and Magnetostrictive Biosensor Materials for Detection of COVID‐19 and Other Viruses

Emerging nanophotonic biosensor technologies for virus detection

Nanotechnology-based diagnostic methods for coronavirus: From nucleic acid extraction to amplification

Advances in nanobiosensors during the COVID-19 pandemic and future perspectives for the post-COVID era

Rapid assays of SARS-CoV-2 virus and noble biosensors by nanomaterials

Recent Advances in Electrochemical and Nanophotonic Biosensors for SARS-CoV-2 Detection

Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses

Microfluidic Device-Based Virus Detection and Quantification in Future Diagnostic Research: Lessons from the COVID-19 Pandemic

Nanotechnology-Based Approaches for the Detection of SARS-CoV-2

Nanomaterials to tackle the COVID-19 pandemic

Nanomaterial-Based Biosensors for the Detection of COVID-19

Nanotechnology-Based Modern Biosensors for the Detection of SARS-CoV-2 Virus